Additional file 5 of Combinatorial functionomics identifies HDAC6-dependent molecular vulnerability of radioresistant head and neck cancer

Additional file 5 (Fig. S5 Class II selective HDAC inhibitor preferentially targets RR-HNC models. Representative immunoblots of histone and non-histone proteins regulated by HDACs in WT and RR a FaDu and b HK-1 treated singly with Romidepsin (class I selective HDACi) or Roybinostat (class II selective HDACi), or in combination with AZD7762 for 48h.)